We studied the effects of stem cell factor (SCF) and flt3 ligand versus-host disease (GVHD). 1, 4, 6 However, the number of pro- for clinical hematopoietic stem cell transplantation. In the present study, we investigated the effect of stem cell human hematopoietic progenitors in the presence of SCF or FL.
14), 60-fold (day 7) and 51-fold (day 14). Other combinations of cytokines without IL-3 failed to expand effectively these com-
tution was achieved in five patients who received only ex vivo mitted progenitors. Our data demonstrate that it is possible to expanded progenitor cells. However, it still remains uncertain expand human CB-derived committed progenitors in vitro whether total hematopoietic reconstitution can truly be using SCF or FL with several other cytokines including TPO, obtained by expanded stem cells transfused.
and that IL-3 is the key cytokine promoting the expansion of
In the present study, we investigated the effect of stem cell human hematopoietic progenitors in the presence of SCF or FL.
factor (SCF) in combination with various cytokines, including
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+ cells in short-term serum-free liquid suspension culture, and compared its effect with that of a ligand for the flt3 tyrosine kinase receptor (FL) . 27 Our data clearly demonstrated Introduction that SCF plus IL-3 most effectively expanded human CBderived committed progenitor cells among the various twoIt is well documented that human umbilical cord blood (CB) factor combinations tested. In contrast to the reported expanis a rich source of stem and progenitor cells.
1-3 Therefore, it sion of murine hematopoietic progenitor cells derived from has been suggested that CB can be used as an alternative to day-2 post-5-FU BM cells, 10 the combination of SCF with ILbone marrow (BM) for reconstituting hematopoiesis in the 6 or IL-11, both of which use gp130 as a signal-transducing allograft setting. In 1989, Gluckman et al 4 first reported hemareceptor component, 28 did not effectively expand CB-derived topoietic reconstitution in a patient with severe Fanconi's anehematopoietic progenitor cells. Interestingly, TPO augmented mia who received cryopreserved CB nucleated cells from a the expansion efficiency (EE) for committed progenitors, sister. This provided evidence that CB-derived hematopoietic including granulocyte/macrophage colony-forming units progenitor cells could be used for effective stem cell trans-(CFU-GM), erythroid burst-forming units (BFU-E) and mixed plantation. To date, the International Cord Blood Transplant colony-forming units (CFU-Mix). The combination of SCF with Registry (ICBTR) lists over 40 allogeneic sibling cord blood IL-3 and IL-6 or IL-11 in the presence of TPO exerted a maxicell transplantations done in children with a variety of maligmal effect on the expansion of these committed progenitors. nant and nonmalignant diseases. 5 The hematopoietic recovery The effect of FL on the expansion of hematopoietic progenitor is slightly slower than after peripheral blood stem cell transcells was inferior to that of SCF in combination with various plantation (PBSCT), but is almost identical with that after allocytokines except TPO. geneic bone marrow transplantation (allo BMT). nations of CSFs. The final concentration of each CSF was as according to the instructions of the manufacturer. The phenofollows: IL-3, 10 ng/ml; GM-CSF, 10 ng/ml; G-CSF, 20 ng/ml; typic purity of these CD34 + cells determined by flow cytoEpo, 2 U/ml; SCF, 20 ng/ml. These concentrations supported metric analysis consistently exceeded 85%. Cytological analymaximal total colony formation in preliminary titration experisis using cytospin preparations stained with May-Grü nwaldments (data not shown). Giemsa revealed that 92 ± 6% of the cells were blastoid in Dishes were incubated at 37°C in a fully humidified atmosmorphology (n = 4). After panning, the recovered cells were phere flushed with a combination of 5% CO 2 , 5% O 2 and washed twice with Iscove's modified Dulbecco's medium 90% N 2 . 29 On days 12-14 of culture, all colonies were scored (IMDM) and cultured as described later.
on an inverted microscope according to their typical morphologic appearance as reported elsewhere. [29] [30] [31] [32] [33] Colony types identified in situ were granulocyte colonies (CFU-G), macrophage colonies (CFU-M), granulocyte/macrophage colonies Recombinant cytokines (CFU-GM), erythroid burst-forming units (BFU-E), eosinophil colonies (CFU-Eo), and mixed colonies containing erythromyeloid cells and megakaryocytes (CFU-Mix). Purified bacterially derived recombinant human IL-3, Average plating efficiency (PE) of CD34 + cells before liquid granulocyte/macrophage (GM) colony-stimulating factor suspension culture was 26 ± 11%. PEs of expanded cells (CSF), granulocyte (G)-CSF, SCF and purified CHO cellvaried widely between different cytokine combinations used derived recombinant human erythropoietin (Epo) were genin liquid suspension cultures. The PEs of expanded cells on erous gifts from Kirin Brewery (Tokyo, Japan). Purified E. colidays 7 and 14 of culture were 20-50% and 7-25%, respectderived recombinant human IL-6 was kindly provided by Dr ively. Akira Okano (Ajinomoto, Yokohama, Japan) and had a spe-
The absolute number and the fold increase of total CFC, cific activity of 6 × 10 6 U/mg protein. Purified recombinant CFU-GM, BFU-E, and CFU-Mix were calculated as follows: human TPO was prepared by the TPO Production Group
(1) Absolute number of colonies = (number of colonies/ (Kirin Brewery, Maebashi, Japan). Purified bacterially derived number of seeded cells) × number of viable nucleated cells; recombinant human IL-11 was a kind gift from Dr Steven C (2) Fold increase = absolute number of colonies on day 7 or Clark (Genetics Institute, Cambridge, MA, USA) and had a day 14/absolute number of colonies on day 0. specific activity of 2.52 × 10 6 U/mg protein. A recombinant soluble form of the human flt3 ligand (FL) was produced in yeast as reported elsewhere. 27 
Statistical analysis
Results expressed as the mean ± s.d. were obtained from tripliShort-term serum-free liquid suspension culture cate experiments performed on separate occasions. The significance of differences in means was determined using the CB-derived CD34 + cells were cultured at 1-3 × 10 3 /ml in 1 ml two-tailed Student's t-test. of IMDM supplemented with 5 × 10 −5 M 2-mercaptoethanol (2-ME; Sigma Chemical, St Louis, MO, USA), 10 g/ml lecithin (Sigma), 6 g/ml cholesterol (Sigma), 300 g/ml fully iron-saturated human transferrin (95% pure, Sigma), 1% Results deionized fraction V bovine serum albumin (BSA, Sigma), 1 g/ml bovine pancreas insulin (Sigma), and various growth Effect of single cytokines on the expansion of cord factors. The concentration of each CSF used in the culture was blood-derived CD34 + cells determined by titration experiments (data not shown) and was as follows: IL-3, 10 ng/ml; IL-6, 100 U/ml; IL-11, 100 U/ml; TPO, 100 ng/ml; SCF, 20 ng/ml; FL, 20 ng/ml. Dishes were First, the effect of single cytokines, including IL-3, IL-6, IL-11, SCF, FL, and TPO, on the expansion of CB-derived CD34 + incubated at 37°C in a fully humidified atmosphere flushed with a combination of 5% CO 2 , 5% O 2 and 90% N 2 for up cells was studied in serum-free culture (Figure 1 ). In the presence of IL-3, total CFC showed a three-fold increase by day to 21 days. We have found that low (5%) oxygen culture was superior to culture in ambient oxygen tension in preliminary 7. In the presence of SCF or TPO, total CFC could be maintained at the initial level by day 14. In contrast, no CFC were experiments (data not shown) as has been reported previously. 29 At specified intervals, the cells were collected by recovered by day 14 in the presence of IL-6 or IL-11, or in the absence of growth factors (data not shown). In the presence of vigorous pipetting and were counted using a counting chamber. Aliquots of cells were used for the colony assay to FL, 30-50% of total CFC present at the initiation of the culture survived by day 14. measure the EE of colony-forming cells (CFC).
Figure 1
The fold increase of total colony-forming cells (CFC) on days 7 and 14 in serum-free liquid suspension cultures in the presence Figure 2 The fold increase of committed progenitors (including of optimal concentrations of single cytokines.
CFU-GM, BFU-E and CFU-Mix) derived from CB CD34 + cells after 7 days of serum-free liquid suspension culture in the presence of SCF and various other cytokines. Data represent the mean ± s.d. of three independent experiments. IL-6 significantly stimulated the expansion Serial changes of the nucleated cell count and of CFU-GM in the presence of SCF + IL-3 (P Ͻ 0.05).
colony-forming cells in the presence of SCF and IL-6
We examined the increase of the total nucleated cell count (NCC) and of CFC in the presence of SCF plus IL-6, which most effectively expanded murine hematopoietic progenitors derived from day-2 post-5-FU BM cells in vitro, as reported elsewhere. 10 The number of viable NCC and total CFC was examined over time for 21 days. Total NCC increased continuously for 14 days and consistently reached approximately 30-fold the input level by day 14. The number of NCC remained at this peak level on day 21 (data not shown). Total CFC also increased continuously until day 14, but subsequently decreased rapidly to return to the initial level by day 21 (data not shown).
Serial changes of different committed progenitors in the presence of SCF + IL-6 were also analyzed. The number of CFU-GM (including CFU-G, CFU-M, CFU-GM and CFU-Eo) increased continuously and reached 10-fold the initial level by day 14. In contrast, the number of BFU-E and CFU-Mix reached a peak by day 7 and the extent of expansion (fivefold) was inferior to that of CFU-GM (data not shown). Based combination was approximately 60-fold, however, this is not Effect of combinations of SCF and IL-3, IL-6 or IL-11 on the expansion of cord blood-derived CD34 + cells significantly larger than that obtained by SCF + IL-3. Expansion of BFU-E and CFU-Mix on day 14 by the combination of SCF + IL-3 + IL-6 or IL-11 (20-to 40-fold increase) was not We next examined the effects of combinations of SCF and IL-3, IL-6 or IL-11 on the expansion of various types of commitsignificantly different from the expansion obtained with SCF + IL-3. These results indicated that IL-6 is more effective for ted progenitors in serum-free culture. Figures 2 and 3 show the mean ± s.d. of three independent experiments. Among the expanding CFU-GM. The combination of SCF + IL-6 + IL-11 did not effectively expand CFC. various two-factor combinations tested, SCF plus IL-3 most effectively expanded CFC. The number of BFU-E increased 50-fold (maximum) on day 7 of culture ( Figure 2) , while the number of CFU-GM and CFU-Mix showed an approximately Effect of combinations of FL and IL-3, IL-6 or IL-11 on the expansion of cord blood-derived CD34 + cells 30 -fold increase on day 14 of culture ( Figure 3 ). In contrast, SCF plus IL-6 or IL-11 did not effectively expand CFC. A threefactor combination (SCF + IL-3 + IL-6) significantly expanded We subsequently examined the effect of a ligand for the flt3 tyrosine kinase receptor (FL) 27 on the expansion of CB-derived CFU-GM on day 7 (P Ͻ 0.05) and the increase was about 30-fold. The EE for CFU-GM on day 14 by the same three-factor CD34 + cells in the presence of IL-3, IL-6 or IL-11, and also
Ex vivo expansion of CD34
؉ cord blood cells Y Ohmizono et al 527 including SCF. Table 1 shows data which represent the mean ± s.d. of three independent experiments. As previously shown, the combination of SCF plus IL-3 most effectively expanded CFC among all the two-factor combinations tested. TPO alone maintained the number of CFC at the initial level. Interestingly, the numbers of CFU-GM and CFU-Mix respectively increased 142-to 197-fold and 19-to 51-fold on day 14 of culture in the presence of SCF + IL-3 + TPO as well as in the presence of SCF + IL-3 + TPO + IL-6 or IL-11. In contrast, the number of BFU-E did not increase in the presence of the same combinations of cytokines. Overall, the maximum EE for CFU-GM (197-fold) and CFU-Mix (51-fold) was obtained on day 14 of culture in the presence of SCF + IL-3 + IL-6 + TPO, while BFU-E reached a peak (60-fold) on day 7 of culture in the presence of SCF + IL-3 + IL-11 + TPO. The EEs for committed progenitors obtained by the combinations of three or four
Figure 4
The fold increase of committed progenitors (including cytokines including TPO appeared to be greater than those cytokines on the expansion of CB-derived CD34 + cells was also investigated (Table 2) . TPO markedly increased the number of CFU-GM, BFU-E and CFU-Mix on day 14 of culture compared its effect with that of SCF. Figures 4 and 5 show the mean ± s.d. of three independent experiments. Among the when combined with FL plus IL-3 as compared to the number of progenitors obtained with FL + IL-3 alone. The EE for each two-factor combinations tested, the combination of FL and IL-3 most effectively expanded CFC (including CFU-GM, BFU-E of the three progenitors was 43-fold, 10-fold, and 45-fold, respectively. The EE for CFU-Mix on day 14 in the presence and CFU-Mix), as was the case with SCF. However, the EE for each progenitor was Ͻ10-fold. When FL, IL-3 and IL-6 were of FL + IL-3 + TPO was almost comparable to that for SCF + IL-3 + IL-6 + TPO. The maximum EE (82-fold) for CFU-GM combined, CFU-GM, BFU-E and CFU-Mix respectively showed a 24-fold, four-fold and five-fold increase on day 14.
was obtained on day 14 of culture in the presence of FL + IL-3 + IL-6 + TPO, indicating that IL-6 preferentially expanded These results indicated that the addition of IL-6 to the culture containing FL + IL-3 significantly expanded only CFU-GM CFU-GM in this combination, just as it did when combined with SCF. The EEs for CFU-GM obtained by this combination compared with those obtained by the two cytokines. However, the EE was much lower than that of SCF.
on both days 7 and 14 were significantly larger than those obtained with FL + IL-3 (P Ͻ 0.05 and P Ͻ 0.02, respectively).
Effect of thrombopoietin on the expansion of cord blood-derived CD34 + cells in the presence of various
Discussion

cytokines
The objective of the present study, was to develop an effective culture system for expansion of human CB-derived CD34 + Finally, we examined the effect of TPO on the expansion of CB-derived CD34 + cells in the presence of various cytokines cells using various cytokines. First, the effect of SCF combined with either IL-6 or IL-11 on the expansion of CB-derived CD34 + cells was examined, but the EE of committed progenitors (including CFU-GM, BFU-E and CFU-Mix) was Ͻ10-fold and was much lower than that obtained in a murine culture system. 10 This discrepancy may be explained by differences of human and murine hematopoietic progenitor cells. Expression of the c-kit receptor on CB-derived CD34 + cells occurs at a level of 58.5 ± 16.7% (n = 19) (Sakabe et al, manuscript in preparation). On the other hand, only 20.2 ± 9.4% (n = 5) of CB-derived CD34
+ cells express the IL-6 receptor ␣ chain (IL-6R␣) (Sakabe et al, unpublished data). This low level of IL-6R␣ expression may partly explain the ineffectiveness of IL-6 in our human culture system.
It is now generally accepted that signals induced by IL-6 or IL-11 are transmitted by a signal transducing receptor component, gp130, after the association of each ligand with the ␣ chain of its receptor. 28 In addition, gp130 is ubiquitously expressed on CB-derived CD34 + cells. 34 As described above, most human CB-derived CD34 + cells did not express the IL- tively than IL-6 alone. Data represent the mean ± s.d. of the absolute number of colonies per 10 3 CD34 + cells after 7 or 14 days of serum-free liquid suspension cultures in the presence of specified cytokines. Data are calculated from three independent experiments using different samples. The statistical analysis was performed for all pairs. Pairs which showed 0.05 Ͻ P Ͻ 0.1 were indicated. (Tables 1 and 2 ). After 7 or However, the combination of sIL-6R and IL-6 with SCF could 14 days of suspension culture in the presence of SCF + IL-3 not expand CB-derived CD34
+ cells as potently in our culture + TPO + IL-6 or IL-11, these reached the maximal numbers system, and the EE for committed progenitors was Ͻ20-fold (average of three experiments), which were approximately (Ohmizono et al, unpublished data).
23 000 CFU-GM, 3700 BFU-E and 1900 CFU-Mix. When FL Our data clearly demonstrated that the combination of SCF was used instead of SCF, TPO markedly increased the EE for plus IL-3 most effectively stimulated the expansion of CB-CFU-GM, BFU-E and CFU-Mix in the presence of IL-3. Howderived committed progenitors among all the two-factor comever, the EE values were inferior to those obtained with SCF, binations that we tested. The maximal EE values for CFU-GM, except that for CFU-Mix. BFU-E and CFU-Mix were approximately 30-to 50-fold after
In conclusion, the present study provides evidence that the 14 days of suspension culture. In contrast, all without IL-3 combination of SCF plus IL-3 effectively expands human CBfailed to expand these committed progenitors effectively.
derived hematopoietic progenitors, and that TPO markedly When FL was used instead of SCF, the pattern of progenitor augments the EE obtained with SCF + IL-3 or FL + IL-3. We expansion was almost identical to that seen with SCF. Again, recently reported that SCF plus either IL-6 or IL-11 most effecthe presence of IL-3 was essential for effective expansion of tively expands murine hematopoietic progenitors, including committed progenitors, but the maximal EE was approxihigh-proliferative potential colony-forming cells (HPP-CFC) mately 20-fold and was much lower than that achieved with derived from day 2 post-5-FU BM cells in vitro. 10 In contrast SCF. As described above, combinations of SCF and several to murine hematopoietic progenitors, IL-3 is the pivotal cytoother cytokines, including IL-3, IL-6 and IL-11, can expand kine for the expansion of human hematopoietic progenitor three types of committed progenitors, CFU-GM, BFU-E and cells in the presence of SCF or FL. It was recently reported CFU-Mix. In contrast, FL fails to effectively expand BFU-E as that IL-3 and IL-1 can inhibit the early stages of murine B-and compared with that of CFU-GM or CFU-Mix, indicating that T-lymphopoiesis, 39,40 while IL-3 or IL-1␣ abrogates the long-SCF and FL have different effects on the expansion of BFU-E.
term reconstituting ability of murine hematopoietic stem Our data are consistent with earlier reports which showed the cells. 41 These observations raise the possibility that IL-3 and synergistic actions of FL or SCF with Pixy 321 (a GM-CSF/IL-IL-1 may suppress the earliest process of hematopoiesis, sug-3 fusion protein) on the expansion of BM-or CB-derived hemgesting that the use of IL-3 for the expansion of human hemaatopoietic progenitor cells. 36, 37 topoietic progenitor or stem cells may need to be reVery recently, we reported that TPO not only acts in megaevaluated. However, Nolta et al 42 recently demonstrated that karyocytopoiesis, but also in the early stage of hematopopluripotent human hematopoietic stem cells give rise to iesis. 38 Therefore, we tested its effect on the expansion of CBlymphoid and myeloid cells in immune-deficient mice after derived CD34
+ cells in the presence of IL-3 and SCF or FL. cotransplantation of transduced human progenitors and Interestingly, the combination of SCF + IL-3 + TPO markedly human IL-3-producing stromal cells. These discrepancies may expanded committed progenitors including CFU-Mix. The EE reflect differences in experimental methods as well as different for CFU-GM, BFU-E and CFU-Mix was 142-fold (day 14), 48-stem cell characteristics in humans and mice. However, fold (day 7) and 36-fold (day 14), respectively. In the presence further studies are needed to elucidate whether long-term of four cytokines (SCF + IL-3 + TPO + IL-6), the EE values for repopulating lympho-myeloid stem cells can be maintained CFU-GM and CFU-Mix increased to 197-fold (day 14) and 51-fold (day 14), respectively, which were the maximum values or expanded in vitro. 
